Jpmorgan Chase & CO Organogenesis Holdings Inc. Transaction History

Jpmorgan Chase & CO

  • $1.23 Trillion
  • Q4 2024

A detailed history of Jpmorgan Chase & CO transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 280,997 shares of ORGO stock, worth $902,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
280,997
Previous 205,943 36.44%
Holding current value
$902,000
Previous $588,000 52.89%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025
BUY
$2.77 - $4.43 $207,899 - $332,489
75,054 Added 36.44%
280,997 $899,000
Q3 2024

Dec 26, 2024
BUY
$2.42 - $3.24 $258,511 - $346,106
106,823 Added 107.77%
205,943 $588,000
Q3 2024

Nov 08, 2024
BUY
$2.42 - $3.24 $258,511 - $346,106
106,823 Added 107.77%
205,943 $588,000
Q2 2024

Dec 26, 2024
SELL
$2.28 - $3.03 $243,556 - $323,673
-106,823 Reduced 51.87%
99,120 $277,000
Q2 2024

Aug 12, 2024
SELL
$2.28 - $3.03 $153,911 - $204,540
-67,505 Reduced 40.51%
99,120 $277,000
Q1 2024

Dec 26, 2024
SELL
$2.61 - $4.49 $102,619 - $176,537
-39,318 Reduced 19.09%
166,625 $473,000
Q1 2024

May 10, 2024
BUY
$2.61 - $4.49 $313,620 - $539,522
120,161 Added 258.61%
166,625 $473,000
Q4 2023

Dec 26, 2024
SELL
$1.97 - $4.21 $314,173 - $671,406
-159,479 Reduced 77.44%
46,464 $190,000
Q4 2023

Feb 12, 2024
SELL
$1.97 - $4.21 $3,116 - $6,660
-1,582 Reduced 3.29%
46,464 $190,000
Q3 2023

Nov 14, 2023
SELL
$2.34 - $4.43 $17,884 - $33,858
-7,643 Reduced 13.72%
48,046 $152,000
Q2 2023

Aug 11, 2023
SELL
$1.9 - $4.3 $406 - $920
-214 Reduced 0.38%
55,689 $184,000
Q1 2023

May 18, 2023
BUY
$1.89 - $2.93 $102,744 - $159,280
54,362 Added 3527.71%
55,903 $119,000
Q1 2023

May 11, 2023
SELL
$1.89 - $2.93 $74,163 - $114,973
-39,240 Reduced 96.22%
1,541 $3,000
Q4 2022

Feb 13, 2023
SELL
$2.48 - $3.43 $60,529 - $83,716
-24,407 Reduced 37.44%
40,781 $110,000
Q3 2022

Nov 14, 2022
BUY
$3.14 - $6.43 $11,297 - $23,135
3,598 Added 5.84%
65,188 $212,000
Q2 2022

Aug 11, 2022
BUY
$4.74 - $8.15 $51,082 - $87,832
10,777 Added 21.21%
61,590 $301,000
Q1 2022

May 11, 2022
BUY
$6.47 - $9.57 $128,960 - $190,749
19,932 Added 64.54%
50,813 $387,000
Q4 2021

Feb 10, 2022
SELL
$9.02 - $13.5 $300,835 - $450,252
-33,352 Reduced 51.92%
30,881 $285,000
Q3 2021

Nov 12, 2021
BUY
$13.71 - $17.18 $880,634 - $1.1 Million
64,233 New
64,233 $915,000

Others Institutions Holding ORGO

# of Institutions
124
Shares Held
62M
Call Options Held
4.3K
Put Options Held
3.9K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $420M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email